ArticleHuman mutation2026
SPP1 as a Critical Regulator of Cardiac Cell Reprogramming Following Myocardial Infarction Through Single-Cell Transcriptomic Analysis.
Article in Human mutation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Cardiovascular mortality remains predominantly driven by acute myocardial infarction (AMI), necessitating comprehensive elucidation of mechanisms governing cardiomyocyte reprogramming for therapeutic advancement. Characterizing molecular dynamics throughout cardiac repair processes presents substantial methodological challenges. Methods: We employed a comprehensive analytical framework combining bulk and single-cell RNA sequencing datasets from AMI patients, utilizing 26 distinct machine learning algorithms to delineate critical regulatory gene signatures associated with cardiac repair. Gene prioritization was achieved through differential expression profiling coupled with consensus clustering methodologies. Functional validation experiments in H9c2 cardiomyoblast cellular models demonstrated that enhanced SPP1 expression is associated with augmented cellular viability and stimulated cardioprotective factor release, though these findings require validation in more physiologically relevant systems. Results: Machine learning architectures successfully identified robust cardiomyocyte reprogramming signatures correlating with cardiac functional restoration. Consensus clustering analysis of 276 genes revealed two phenotypically distinct repair subtypes demonstrating divergent recovery trajectories ( Conclusion: This machine learning-driven approach successfully identified novel candidate prognostic biomarkers and potential therapeutic targets for cardiac repair interventions, substantially advancing mechanistic understanding of postinfarction cardiac remodeling processes. These findings generate testable hypotheses requiring validation in independent clinical cohorts and more physiologically relevant experimental systems.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.